---
title: "SANAI HEALTH GP's subsidiary plans to sell 99% equity of Luan Nan Hang Yang Health Industry for 18.69 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265174497.md"
description: "SANAI HEALTH GP announced that its subsidiary Beijing Hangyang Health Technology Co., Ltd. will sell 99% of the equity in Luanan Hangyang Health Industry Co., Ltd. for approximately RMB 18.69 million. The target company has not yet begun operations and was originally planned to expand health product manufacturing facilities, but this has been terminated due to unfavorable market conditions. This sale will generate additional cash flow for the company, improve its liquidity position, and allow it to focus on its core business"
datetime: "2025-11-10T14:19:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265174497.md)
  - [en](https://longbridge.com/en/news/265174497.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265174497.md)
---

# SANAI HEALTH GP's subsidiary plans to sell 99% equity of Luan Nan Hang Yang Health Industry for 18.69 million yuan

According to the announcement from SANAI HEALTH GP (01889), on November 10, 2025, the seller Beijing Hangyang Health Technology Co., Ltd. (a non-wholly-owned subsidiary of the company) and the buyer Xue Wenfen entered into a share transfer agreement regarding the sale, under which the seller has agreed to sell, and the buyer has agreed to purchase shares for approximately RMB 18.69 million, to be settled in cash.

According to the agreement, the seller has agreed to sell, and the buyer has agreed to purchase 99% of the shares of the target company Luan Nan Hangyang Health Industry Co., Ltd.

The target company is an indirect non-wholly-owned subsidiary of the company and a limited company established in China, which has not yet commenced operations. It currently holds a plot of land located on the north side of Zhongda Street and the west side of Jinxiu Road in the Luan Nan City West Industrial Zone, with an area of approximately 67,000 square meters.

Since its establishment in January 2018, the target company has not engaged in actual operations. The plot of land held by the target company was originally planned for the construction of production facilities to expand the capacity of health products. However, due to recent unfavorable market conditions, its management has decided to terminate the expansion plan.

The board of directors believes that continuing to hold shares in the target company, and thus holding the land, may not generate the best returns for shareholders. The company believes that the sale represents an ideal opportunity to create additional cash flow. Divesting the target company will allow the group to streamline its operations, obtain additional funds, and reallocate resources to markets and business segments where the group has stronger competitive advantages and expertise.

The total net proceeds from the sale (after deducting related expenses) are estimated to be approximately RMB 18.68 million, which the company intends to use for general working capital and other business development. Upon completion, the sale is expected to improve the group's liquidity position, thereby strengthening its financial condition, while allowing the group to focus on its core business

### Related Stocks

- [01889.HK](https://longbridge.com/en/quote/01889.HK.md)

## Related News & Research

- [CITIC Resets Aluminium Hub Procurement Deal After Adding New Connected Suppliers](https://longbridge.com/en/news/290959758.md)
- [CITIC Limited shareholders pass AGM resolutions by poll vote](https://longbridge.com/en/news/290955279.md)
- [Fusen Pharmaceutical Wins China Nod for Peramivir Flu Injection](https://longbridge.com/en/news/290914836.md)
- [Soitec says CDC beneficial stake falls to 12.16% of capital, 17.84% voting rights](https://longbridge.com/en/news/290845925.md)
- [MMG Wins Vienna Listing for US$800 Million Convertible Bonds](https://longbridge.com/en/news/290591233.md)